⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CELU News
Celularity Inc. Class A Common Stock
Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision
globenewswire.com
CELU
Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care
globenewswire.com
CELU
Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease
globenewswire.com
CELU